Jaclyn Winter - Publications

Affiliations: 
University of Utah, Salt Lake City, UT 
Area:
Secondary metabolites, Bacteria, Fungi
Website:
http://pharmacy.utah.edu/medchem/faculty/current-faculty/Winter_J.php

38 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2017 Agarwal V, Miles ZD, Winter JM, Eustáquio AS, El Gamal AA, Moore BS. Enzymatic Halogenation and Dehalogenation Reactions: Pervasive and Mechanistically Diverse. Chemical Reviews. PMID 28106994 DOI: 10.1021/Acs.Chemrev.6B00571  0.96
2016 Sato M, Winter JM, Kishimoto S, Noguchi H, Tang Y, Watanabe K. Combinatorial Generation of Chemical Diversity by Redox Enzymes in Chaetoviridin Biosynthesis. Organic Letters. PMID 26959241 DOI: 10.1021/Acs.Orglett.6B00380  0.96
2016 Xu-Monette ZY, Zhang S, Li X, Manyam GC, Wang Xx, Xia Y, Visco C, Tzankov A, Zhang L, Montes-Moreno S, Dybkaer K, Chiu A, Orazi A, Zu Y, Bhagat G, ... ... Winter JN, et al. p63 expression confers significantly better survival outcomes in highrisk diffuse large B-cell lymphoma and demonstrates p53-like and p53-independent tumor suppressor function Aging. 8: 345-365.  0.36
2015 Winter JN, Peterson LC. Lymphocytosis, lymphadenopathy: benign or malignant? Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program. 2015: 106-10. PMID 26637708 DOI: 10.1182/asheducation-2015.1.106  0.01
2015 Ye Q, Xu-Monette ZY, Tzankov A, Deng L, Wang X, Manyam GC, Visco C, Montes-Moreno S, Zhang L, Dybkær K, Chiu A, Orazi A, Zu Y, Bhagat G, Richards KL, ... ... Winter JN, et al. Prognostic impact of concurrent MYC and BCL6 rearrangements and expression in de novo diffuse large B-cell lymphoma. Oncotarget. PMID 26573234 DOI: 10.18632/oncotarget.6262  0.36
2015 Xu-Monette ZY, Dabaja BS, Wang X, Tu M, Manyam GC, Tzankov A, Xia Y, Zhang L, Sun R, Visco C, Dybkaer K, Yin L, Chiu A, Orazi A, Zu Y, ... ... Winter JN, et al. Clinical features, tumor biology, and prognosis associated with MYC rearrangement and Myc overexpression in diffuse large B-cell lymphoma patients treated with rituximab-CHOP. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. PMID 26541272 DOI: 10.1038/Modpathol.2015.118  0.36
2015 Vidula N, Villa M, Helenowski IB, Merchant M, Jovanovic BD, Meagher R, Mehta J, Singhal S, Winter JN, Frankfurt O, Altman JK, Williams SF, Gordon LI. Adverse Events During Hematopoietic Stem Cell Infusion: Analysis of the Infusion Product. Clinical Lymphoma, Myeloma & Leukemia. PMID 26482109 DOI: 10.1016/j.clml.2015.08.085  0.36
2015 Martinez-Escala ME, Guggina LM, Cotliar J, Winter JN, Guitart J. Cutaneous Involvement in a Case of Intravascular T-Cell Lymphoma With a γδ Phenotype. The American Journal of Dermatopathology. PMID 26460624 DOI: 10.1097/DAD.0000000000000383  0.36
2015 Li L, Xu-Monette ZY, Ok CY, Tzankov A, Manyam GC, Sun R, Visco C, Zhang M, Montes-Moreno S, Dybkaer K, Chiu A, Orazi A, Zu Y, Bhagat G, Richards KL, ... ... Winter JN, et al. Prognostic impact of c-Rel nuclear expression and REL amplification and crosstalk between c-Rel and the p53 pathway in diffuse large B-cell lymphoma. Oncotarget. PMID 26324762  0.2
2015 Liu Z, Xu-Monette ZY, Cao X, Manyam GC, Wang X, Tzankov A, Xia Y, Li X, Visco C, Sun R, Zhang L, Montes-Moreno S, Dybkær K, Chiu A, Orazi A, ... ... Winter JN, et al. Prognostic and biological significance of survivin expression in patients with diffuse large B-cell lymphoma treated with rituximab-CHOP therapy. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. PMID 26248897 DOI: 10.1038/modpathol.2015.94  0.36
2015 Winter JM, Cascio D, Dietrich D, Sato M, Watanabe K, Sawaya MR, Vederas JC, Tang Y. Biochemical and Structural Basis for Controlling Chemical Modularity in Fungal Polyketide Biosynthesis. Journal of the American Chemical Society. PMID 26172141 DOI: 10.1021/Jacs.5B04520  0.96
2015 Xu-Monette ZY, Tu M, Jabbar KJ, Cao X, Tzankov A, Visco C, Nagarajan L, Cai Q, Montes-Moreno S, An Y, Dybkaer K, Chiu A, Orazi A, Zu Y, Bhagat G, ... ... Winter JN, et al. Erratum: Clinical and biological significance of de novo CD5+ diffuse large B-cell lymphoma in Western countries. Oncotarget. 6: 14720. PMID 26116824  0.2
2015 Ok CY, Xu-Monette ZY, Li L, Manyam GC, Montes-Moreno S, Tzankov A, Visco C, Dybkær K, Routbort MJ, Zhang L, Chiu A, Orazi A, Zu Y, Bhagat G, Richards KL, ... ... Winter JN, et al. Evaluation of NF-κB subunit expression and signaling pathway activation demonstrates that p52 expression confers better outcome in germinal center B-cell-like diffuse large B-cell lymphoma in association with CD30 and BCL2 functions. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. PMID 26111978 DOI: 10.1038/modpathol.2015.76  0.36
2015 Ok CY, Ye Q, Li L, Manyam GC, Deng L, Goswami RR, Wang X, Montes-Moreno S, Visco C, Tzankov A, Dybkaer K, Zhang L, Abramson J, Sohani AR, Chiu A, ... ... Winter JN, et al. Age cutoff for Epstein-Barr virus-positive diffuse large B-cell lymphoma - is it necessary? Oncotarget. 6: 13935-13946. PMID 26101854  0.36
2015 Hoppe RT, Advani RH, Ai WZ, Ambinder RF, Aoun P, Bello CM, Benitez CM, Bierman PJ, Blum KA, Chen R, Dabaja B, Forero A, Gordon LI, Hernandez-Ilizaliturri FJ, Hochberg EP, ... ... Winter JN, et al. Hodgkin lymphoma, version 2.2015. Journal of the National Comprehensive Cancer Network : Jnccn. 13: 554-86. PMID 25964641 DOI: 10.6004/Jnccn.2015.0075  0.08
2015 Xu-Monette ZY, Tu M, Jabbar KJ, Cao X, Tzankov A, Visco C, Cai Q, Montes-Moreno S, An Y, Dybkaer K, Chiu A, Orazi A, Zu Y, Bhagat G, Richards KL, ... ... Winter JN, et al. Clinical and biological significance of de novo CD5+ diffuse large B-cell lymphoma in Western countries. Oncotarget. 6: 5615-33. PMID 25760242  0.2
2015 Chen J, Xu-Monette ZY, Deng L, Shen Q, Manyam GC, Martinez-Lopez A, Zhang L, Montes-Moreno S, Visco C, Tzankov A, Yin L, Dybkaer K, Chiu A, Orazi A, Zu Y, ... ... Winter JN, et al. Dysregulated CXCR4 expression promotes lymphoma cell survival and independently predicts disease progression in germinal center B-cell-like diffuse large B-cell lymphoma. Oncotarget. 6: 5597-614. PMID 25704881  0.36
2015 Zhou Z, Gao J, Popovic R, Wolniak K, Parimi V, Winter JN, Licht JD, Chen YH. Strong expression of EZH2 and accumulation of trimethylated H3K27 in diffuse large B-cell lymphoma independent of cell of origin and EZH2 codon 641 mutation. Leukemia & Lymphoma. 1-7. PMID 25651430 DOI: 10.3109/10428194.2015.1006220  0.36
2015 Jacobsen ED, Sharman JP, Oki Y, Advani RH, Winter JN, Bello CM, Spitzer G, Palanca-Wessels MC, Kennedy DA, Levine P, Yang J, Bartlett NL. Brentuximab vedotin demonstrates objective responses in a phase 2 study of relapsed/refractory DLBCL with variable CD30 expression. Blood. 125: 1394-402. PMID 25573987 DOI: 10.1182/blood-2014-09-598763  0.36
2015 Patel AB, Chen YH, Zhang Y, Frankfurt O, Winter JN. Achievement of morphologic and cytogenetic remission with single-agent hydroxyurea in a patient with acute myeloid leukemia with inv(16). Leukemia & Lymphoma. 56: 817-9. PMID 25012942 DOI: 10.3109/10428194.2014.938332  0.36
2015 Frankfurt O, Ma S, Gordon L, Winter JN, Horowitz JM, Rademaker A, Weitner BB, Peterson LC, Altman JK, Tallman MS, Petrich A, Rosen ST. Phase II study of alemtuzumab-rituximab therapy in previously untreated patients with chronic lymphocytic leukemia: short- and long-term outcomes. Leukemia & Lymphoma. 56: 315-23. PMID 24707943 DOI: 10.3109/10428194.2014.910654  0.36
2015 Li L, Xu-Monette ZY, Ok CY, Tzankov A, Manyam GC, Sun R, Visco C, Zhang M, Montes-Moreno S, Dybkaer K, Chiu A, Orazi A, Zu Y, Bhagat G, Richards KL, ... ... Winter JN, et al. Prognostic impact of c-Rel nuclear expression and REL amplification and crosstalk between c-Rel and the p53 pathway in diffuse large B-cell lymphoma Oncotarget. 6: 23157-23180. DOI: 10.18632/oncotarget.4319  0.36
2014 Winter JM, Tang Y. Natural products: Getting a handle on peptides. Nature Chemistry. 6: 1037-8. PMID 25411879 DOI: 10.1038/nchem.2117  0.96
2014 Ok CY, Chen J, Xu-Monette ZY, Tzankov A, Manyam GC, Li L, Visco C, Montes-Moreno S, Dybkær K, Chiu A, Orazi A, Zu Y, Bhagat G, Richards KL, Hsi ED, ... ... Winter JN, et al. Clinical implications of phosphorylated STAT3 expression in De Novo diffuse large B-cell lymphoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 20: 5113-23. PMID 25124685 DOI: 10.1158/1078-0432.CCR-14-0683  0.36
2014 de Vos S, Forero-Torres A, Ansell SM, Kahl B, Cheson BD, Bartlett NL, Furman RR, Winter JN, Kaplan H, Timmerman J, Whiting NC, Drachman JG, Advani R. A phase II study of dacetuzumab (SGN-40) in patients with relapsed diffuse large B-cell lymphoma (DLBCL) and correlative analyses of patient-specific factors. Journal of Hematology & Oncology. 7: 44. PMID 24919462 DOI: 10.1186/1756-8722-7-44  0.36
2014 Gandhi MD, Evens AM, Fenske TS, Hamlin P, Coiffier B, Engert A, Moskowitz AJ, Ghosh N, Petrich AM, Lomasney J, Chadburn A, Wood GS, Salva K, Nardone B, Trifilio SM, ... ... Winter JN, et al. Pancreatitis in patients treated with brentuximab vedotin: a previously unrecognized serious adverse event. Blood. 123: 2895-7. PMID 24786458 DOI: 10.1182/Blood-2014-03-561878  0.36
2014 Evens AM, Smith MR, Lossos IS, Helenowski I, Millenson M, Winter JN, Rosen ST, Gordon LI. Frontline bortezomib and rituximab for the treatment of newly diagnosed high tumour burden indolent non-Hodgkin lymphoma: a multicentre phase II study. British Journal of Haematology. 166: 514-20. PMID 24761968 DOI: 10.1111/bjh.12915  0.04
2014 Nelson BP, Abdul-Nabi A, Goolsby C, Winter J, Peterson L. Characterization of tissue findings in bone marrow biopsy specimens with small monoclonal B-cell populations. American Journal of Clinical Pathology. 141: 687-96. PMID 24713740 DOI: 10.1309/Ajcpd5Tobdju4Gko  0.01
2013 Winter JM, Chiou G, Bothwell IR, Xu W, Garg NK, Luo M, Tang Y. Expanding the structural diversity of polyketides by exploring the cofactor tolerance of an inline methyltransferase domain. Organic Letters. 15: 3774-7. PMID 23837609 DOI: 10.1021/Ol401723H  0.96
2012 Winter JM, Sato M, Sugimoto S, Chiou G, Garg NK, Tang Y, Watanabe K. Identification and characterization of the chaetoviridin and chaetomugilin gene cluster in Chaetomium globosum reveal dual functions of an iterative highly-reducing polyketide synthase. Journal of the American Chemical Society. 134: 17900-3. PMID 23072467 DOI: 10.1021/Ja3090498  0.96
2012 Winter JM, Tang Y. Synthetic biological approaches to natural product biosynthesis Current Opinion in Biotechnology. 23: 736-743. PMID 22221832 DOI: 10.1016/j.copbio.2011.12.016  0.96
2011 Udwary DW, Gontang EA, Jones AC, Jones CS, Schultz AW, Winter JM, Yang JY, Beauchemin N, Capson TL, Clark BR, Esquenazi E, Eustáquio AS, Freel K, Gerwick L, Gerwick WH, et al. Significant natural product biosynthetic potential of actinorhizal symbionts of the genus frankia, as revealed by comparative genomic and proteomic analyses. Applied and Environmental Microbiology. 77: 3617-25. PMID 21498757 DOI: 10.1128/Aem.00038-11  0.96
2011 Bernhardt P, Okino T, Winter JM, Miyanaga A, Moore BS. A stereoselective vanadium-dependent chloroperoxidase in bacterial antibiotic biosynthesis. Journal of the American Chemical Society. 133: 4268-70. PMID 21384874 DOI: 10.1021/Ja201088K  0.96
2011 Winter JM, Behnken S, Hertweck C. Genomics-inspired discovery of natural products. Current Opinion in Chemical Biology. 15: 22-31. PMID 21111667 DOI: 10.1016/J.Cbpa.2010.10.020  0.96
2009 Winter JM, Moore BS. Exploring the chemistry and biology of vanadium-dependent haloperoxidases. The Journal of Biological Chemistry. 284: 18577-81. PMID 19363038 DOI: 10.1074/Jbc.R109.001602  0.96
2009 Winter JM, Jansma AL, Handel TM, Moore BS. Formation of the pyridazine natural product azamerone by biosynthetic rearrangement of an aryl diazoketone. Angewandte Chemie (International Ed. in English). 48: 767-70. PMID 19072974 DOI: 10.1002/Anie.200805140  0.96
2007 Winter JM, Moffitt MC, Zazopoulos E, McAlpine JB, Dorrestein PC, Moore BS. Molecular basis for chloronium-mediated meroterpene cyclization: cloning, sequencing, and heterologous expression of the napyradiomycin biosynthetic gene cluster. The Journal of Biological Chemistry. 282: 16362-8. PMID 17392281 DOI: 10.1074/Jbc.M611046200  0.96
2006 Cifuentes M, Schilling B, Ravindra R, Winter J, Janik ME. Synthesis and biological evaluation of B-ring modified colchicine and isocolchicine analogs Bioorganic and Medicinal Chemistry Letters. 16: 2761-2764. PMID 16504507 DOI: 10.1016/j.bmcl.2006.02.010  0.96
Show low-probability matches.